investors.xencor.com investors.xencor.com

investors.xencor.com

Investor Relations - Xencor, Inc.

The Investor Relations website contains information about Xencor, Inc. business for stockholders, potential investors, and financial analysts.

http://investors.xencor.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.XENCOR.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.5 out of 5 with 10 reviews
5 star
6
4 star
3
3 star
1
2 star
0
1 star
0

Hey there! Start your review of investors.xencor.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.2 seconds

CONTACTS AT INVESTORS.XENCOR.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Relations - Xencor, Inc. | investors.xencor.com Reviews
<META>
DESCRIPTION
The Investor Relations website contains information about Xencor, Inc. business for stockholders, potential investors, and financial analysts.
<META>
KEYWORDS
1 sitemap
2 management
3 board of directors
4 scientific advisory board
5 pipeline
6 xmab
7 clinical trials
8 technology
9 antibody engineering technology
10 half life extension technology
CONTENT
Page content here
KEYWORDS ON
PAGE
sitemap,management,board of directors,scientific advisory board,pipeline,xmab,clinical trials,technology,antibody engineering technology,half life extension technology,bispecific technology,publications,partners,alliances,investors,press releases,news
SERVER
Microsoft-IIS/6.0
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Relations - Xencor, Inc. | investors.xencor.com Reviews

https://investors.xencor.com

The Investor Relations website contains information about Xencor, Inc. business for stockholders, potential investors, and financial analysts.

INTERNAL PAGES

investors.xencor.com investors.xencor.com
1

Xencor, Inc. | Investors

http://investors.xencor.com/index.cfm

Immune Inhibitor Fc Domains. Nov 7, 2016 at 6:00 PM ET. Credit Suisse 25th Annual Healthcare Conference. November 7, 2016. Nov 2, 2016 at 4:30 PM ET. Q3 2016 Xencor, Inc. Earnings Conference Call. Nov 2, 2016. Xencor Reports Third Quarter 2016 Financial Results. Oct 31, 2016. Xencor to Present at Upcoming Investor Conferences. View all press releases ».

2

Xencor, Inc. | Events & Presentations

http://investors.xencor.com/events.cfm

Immune Inhibitor Fc Domains. Nov 13, 2016. 2:30 PM - 4:00 PM ET. American College of Rheumatology (ACR) 2016 Annual Meeting. American College of Rheumatology (ACR) 2016 Annual Meeting. Please sign up for Email alerts. Archived Investor Events and Presentations. Nov 7, 2016. Credit Suisse 25th Annual Healthcare Conference. Nov 7, 2016. Nov 2, 2016. Q3 2016 Xencor, Inc. Earnings Conference Call. Sep 29, 2016. The LEERINK Partners Rare Disease and Immuno-Oncology Roundtable. Sep 7, 2016. Aug 17, 2016. Ameri...

3

Xencor, Inc. | Investor FAQs

http://investors.xencor.com/faq.cfm

Immune Inhibitor Fc Domains. On what stock exchange are Xencor shares traded, and what is the ticker symbol? Xencor shares are traded on the NASDAQ under the symbol XNCR. When was Xencor's Initial Public Offering? Where is Xencor's corporate headquarters? 111 W Lemon Ave. Monrovia, CA 91016. When does Xencor's fiscal year end? Who are the company's independent registered public accountants? RSM US, LLP. Who is Xencor's transfer agent? 1 800 962-4284 (US, Canada, PR). 1 781 575-3120 (non-US).

4

Xencor, Inc. | Board of Directors

http://investors.xencor.com/directors.cfm

Immune Inhibitor Fc Domains. Bassil I. Dahiyat, Ph.D. President and Chief Executive Officer, Director. Bruce L.A. Carter, Ph.D. Chairman of the Board and Director. Member of the Nominating and Governance Committee. Chair of the Compensation Committee. Robert Baltera, Jr., M.S., M.B.A. Member of the Audit Committee. Chair of the Nominating and Governance Committee. Chair of the Audit Committee. Member of the Compensation Committee. A Bruce Montgomery, MD. Member of the Audit Committee. Yujiro S. Hata.

5

Xencor, Inc. | Management

http://investors.xencor.com/management.cfm

Immune Inhibitor Fc Domains. Bassil I. Dahiyat, Ph.D. President and Chief Executive Officer, Director. Edgardo Baracchini, Ph.D. Most recently, he served as senior vice president of business development at Metabasis Therapeutics until its merger with Ligand Pharmaceuticals in 2009. Prior to joining Metabasis, Dr. Baracchini was vice president of business development at Elitra Pharmaceuticals, and the director of business development at Agouron Pharmaceuticals until its acquisition by Warner-Lambe...Dr Ba...

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

SOCIAL ENGAGEMENT



OTHER SITES

investors.ws investors.ws

Home

Undefined variable: isAdmin in /home/investors/public html/html/header.php. Login / Sign up. Where you can manage free online currencies transfer. JOIN NOW FOR FREE. COUNTRY: GLBL CURRENCIES: USD,EUR,. COUNTRY: GLBL CURRENCIES: USD,. COUNTRY: GLBL CURRENCIES: USD,. COUNTRY: GLBL CURRENCIES: USD,EUR,.

investors.wsfsbank.com investors.wsfsbank.com

Investor Relations | WSFS Financial Corporation

Skip to main navigation. WSFS bank - We Stand For Service. Log In to Your Account. Select Your Account Type. Enroll in Online Banking. WSFS Financial Corporation is a multi-billion dollar financial services company. Its principal subsidiary, WSFS Bank. Serving our communities since 1832, WSFS Bank is one of the ten oldest banks in the United States continuously operating under the same name. Other subsidiaries or divisions of WSFS Financial Corporation are as follows:. Provides comprehensive trustee, age...

investors.xactlycorp.com investors.xactlycorp.com

Xactly Corporation - Investors - Overview

1866GO.XACTLY (469.2285). Xactly is a leading provider of enterprise-class, cloud-based, incentive compensation SaaS solutions for employee and SPM. We empower organizations to incentivize employees, mitigate risk, make data-backed decisions, design better comp plans, and inspire performance. August 11, 2015. EWAY Selects Xactly to Motivate Sales and Boost Employee Satisfaction. August 5, 2015. Xactly Named Top Incentive Management Provider in CRM Magazine Market Leader Awards. August 4, 2015. Excellence...

investors.xbiotech.com investors.xbiotech.com

Investor Overview - Xbiotech Investor Relations

Data provided by Nasdaq. Minimum 15 minutes delayed. XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide. XBiotech Completes Enrollment for Xilonix(TM) Phase III Registration Study in Europe. XBiotech Announces Expansion of Global Phase 3 Registration Study in Europe using Xilonix(TM) for Treatment of Metastatic Colorectal Cancer. There are currently no events scheduled.

investors.xceedmortgage.com investors.xceedmortgage.com

IntegrateIR

Enter any ticker symbol here to see the live quote and chart tools in action. It gives you the power. To provide dynamic real-time and delayed quotes, charts, filings, news and disclosure tools to your customers and shareholders. Allowing you to provide all these things at a fraction of the cost of traditional internal methods. It helps your company adhere. To recommended regulatory guidelines and disclosure rules. Your regulatory filings through automation. It can be seamlessly. It can be quickly. This ...

investors.xencor.com investors.xencor.com

Investor Relations - Xencor, Inc.

IIb Immune Inhibitor Technology. Cytotoxic Fc Domain Technology. Xencor Inc. 2015 R&D Day. June 26, 2015. EULAR 2015 Poster Presentation. June 12, 2015. June 3, 2015. Aug 4, 2015. Xencor Reports Second Quarter 2015 Financial and Operating Results. Aug 4, 2015. Xencor to Present at 2015 Wedbush PacGrow Healthcare Conference. Aug 11, 2015 at 10:55 AM ET. 2015 Wedbush PacGrow Healthcare Conference. Aug 4, 2015 at 4:30 PM ET. Q2 2015 Xencor, Inc. Earnings Conference Call.

investors.xeniareit.com investors.xeniareit.com

Corporate Overview - Xenia Hotels & Resorts

Email Alerts / Investor Information. 021 - 1.05 %. As of August 18, 2015 2:01 PM -. Minimum 20 minute delay. Second Quarter 2015 Earnings Conference Call. Thursday, August 13, 2015. Live Toll-Free (855) 656-0921. Xenia Hotels and Resorts, Inc. Xenia Hotels and Resorts Reports Second Quarter 2015 Results. Xenia Hotels and Resorts Agrees To Acquire The Hotel Commonwealth In Boston, Massachusetts. The ONE Group Announces STK Rebel Will Open in Andaz San Diego. Xenia Hotels and Resorts, Inc. Orlando, FL 32801.

investors.xoma.com investors.xoma.com

Investor Relations | XOMA Corporation

Skip to main navigation. Assets Available for Licensure. The Company intends to build upon its current portfolio by employing multiple strategies to acquire additional license interests (i.e. milestones and royalties) in partner-funded programs. If XOMA license holders successfully advance product candidates towards regulatory approval and ultimately commercialization, the Company will receive milestone payments and royalty revenues without any additional investment. Mar 29, 2018 5:36 PM EDT. Mar 07, 2018.

investors.xpologistics.com investors.xpologistics.com

Investors | Investors | XPO Logistics

Skip to main content. Stock Quote and Chart. Code of Business Conduct and Ethics. Senior Officer Code of Business Conduct and Ethics. XPO serves more than 30,000 customers with a highly integrated network of over 54,000 employees and 887 locations in 27 countries. The company's corporate headquarters is in Greenwic. XPO Logistics Announces Second Quarter 2015 Results. XPO Logistics Schedules Second Quarter 2015 Conference Call for Thursday, August 6, 2015. XPO Logistics Acquires Norbert Dentressangle.

investors.xyleminc.com investors.xyleminc.com

Xylem: Let's Solve Water | Investor Relations | Overview

Xylem Inc. to participate in the 2015 Canaccord Genuity 35th Annual Growth Conference. Xylem Inc. reports second quarter 2015 earnings. Xylem awarded $6M rental contract for Panama Canal expansion project. Xylem Inc. Chief Financial Officer Resigns to Accept Another Opportunity. Company Provides Preliminary Second Quarter 2015 Financial Results RYE BROOK, N.Y.- (BUSINESS WIRE)- Jul. 13, 2015- Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s...Texas student...

investors.xyz investors.xyz

investors.xyz

The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).